Company Description
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally.
It operates in four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V.
site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wrap, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers.
Its Dental Solutions segment provides a suite of dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents.
The Health Information Systems provides software solutions and services for health care systems, such as computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms.
Its Purification and Filtration segment provides purification and filtration technologies comprising filters, purifiers, cartridges, and membranes.
The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce.
Solventum Corporation was incorporated in 2023 and is based in Maplewood, Minnesota.
| Country | United States |
| Founded | 2023 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 22,000 |
| CEO | Bryan Hanson |
Contact Details
Address: 3M Center, Building 275-6W-20 Maplewood, Minnesota 55144-1000 United States | |
| Phone | 651 733 1110 |
| Website | solventum.com |
Stock Details
| Ticker Symbol | SOLV |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001964738 |
| CUSIP Number | 83444M101 |
| ISIN Number | US83444M1018 |
| Employer ID | 92-2008841 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Bryan C. Hanson | Chief Executive Officer and Director |
| Wayde D. McMillan | Chief Financial Officer |
| Amy Landucci | Chief Information and Digital Officer |
| Tammy L. Gomez | Chief Human Resources Officer |
| J. Christopher Barry | Executive Vice President and Group President of Medical Surgical |
| Mary T. Wilcox | Senior Vice President, Corporate Controller and Chief Accounting Officer |
| Amy Wakeham | Senior Vice President of Investor Relations and External Finance Communications |
| Marcela A. Kirberger | Chief Legal Affairs Officer and Corporate Secretary |
| Kate Dobbs | Chief Communications and Brand Officer |
| Rachel H. Ellingson | Chief Strategy and Corporate Development Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 21, 2025 | ARS | Filing |
| Mar 21, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 21, 2025 | DEF 14A | Other definitive proxy statements |
| Feb 28, 2025 | IRANNOTICE | Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 |
| Feb 28, 2025 | 10-K | Annual Report |
| Feb 27, 2025 | 8-K | Current Report |
| Feb 27, 2025 | 8-K | Current Report |
| Dec 17, 2024 | EFFECT | Notice of Effectiveness |
| Dec 11, 2024 | POS AM | Post-Effective amendments for registration statement |
| Dec 10, 2024 | 4/A | [Amend] Statement of changes in beneficial ownership of securities |